Frank McGillin

Chief Commercial Officer, Neurometrix

Frank McGillin

Chief Commercial Officer, Neurometrix

Biography

Frank is Chief Commercial Officer at Neurometrix where he is leading the creation of a new therapeutic category with the launch of Quell® Wearable Pain Relief Technology™, an FDA cleared, 100% drug free alternative for managing chronic pain. Quell was the winner of the 2016 SXSW Innovation Award for Wearable Technology and one of four health and fitness finalists for the Best of CES. After a successful crowdfunding campaign on Indiegogo, Quell is now available online and through major US retailers including Amazon, CVS, Best Buy and others. Quell has been covered extensively in national media including Good Morning America, CBS News, Forbes, Fortune, Wired and Men’s Health. The new Quell 2.0, recently launched in September 2019, was named a 2019 CES Innovation Awards Honoree in the Fitness, Sports and Biotech product category.

Frank has over 20 years of experience building successful, high-growth consumer health and technology brands at Philips and Johnson & Johnson, launching over 50 new products and leading global expansion of Sonicare. He has a passion for innovation in digital health.

All session by Frank McGillin